41 related articles for article (PubMed ID: 12087679)
1. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
[TBL] [Abstract][Full Text] [Related]
3. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
4. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
5. Association of advanced glycation end products in Dupuytren disease.
Takase F; Mifune Y; Inui A; Ueda Y; Kataoka T; Kokubu T; Kuroda R
J Orthop Surg Res; 2018 Jun; 13(1):143. PubMed ID: 29880057
[TBL] [Abstract][Full Text] [Related]
6. Dupuytren's: a systems biology disease.
Rehman S; Goodacre R; Day PJ; Bayat A; Westerhoff HV
Arthritis Res Ther; 2011; 13(5):238. PubMed ID: 21943049
[TBL] [Abstract][Full Text] [Related]
7. Fibroblasts and myofibroblasts in wound healing: force generation and measurement.
Li B; Wang JH
J Tissue Viability; 2011 Nov; 20(4):108-20. PubMed ID: 19995679
[TBL] [Abstract][Full Text] [Related]
8. The myofibroblast in Dupuytren's contracture.
Rudolph R; Vande Berg J
Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of Dupuytren's contracture--a review].
Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
[TBL] [Abstract][Full Text] [Related]
10. [The pathobiochemistry of Dupuytren's contracture].
Bobiński R
Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
12. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
13. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
14. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.
Berndt A; Kosmehl H; Mandel U; Gabler U; Luo X; Celeda D; Zardi L; Katenkamp D
Histochem J; 1995 Dec; 27(12):1014-20. PubMed ID: 8789403
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
